December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 03, 2024CorporateMulti-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients
December 03, 2024CorporateTerumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support CatheterProvides interventionalists with optimal product choices for more complex radial-to-peripheral procedures
The Latest Materials 1st Half Financial Results for FYE 3/2025 November 07, 2024 Financial Statements IFRS Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2025 (PDF 420.15 KB) Presentation Material Beyond GS26: Innovation Strategy (PDF 2.51 MB) Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2025 (FY2024) (PDF 1.16 MB) Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2025 (FY2024)(with note) (PDF 392.11 KB) Additional Information Corporate Data File for the Second Quarter of FY 2024 (PDF 565.49 KB) Corporate Data File for the Second Quarter of FY 2024 (Excel 302.25 KB) Q&A Q&A Session at the Financial Results Briefing for the Second Quarter of Fiscal Year Ending March 31, 2025 (PDF 153.17 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
IFRS Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2025 (PDF 420.15 KB)
Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2025 (FY2024)(with note) (PDF 392.11 KB)
Q&A Session at the Financial Results Briefing for the Second Quarter of Fiscal Year Ending March 31, 2025 (PDF 153.17 KB)